Clark Estates Inc. NY Cuts Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Clark Estates Inc. NY lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 7.4% during the third quarter, Holdings Channel reports. The institutional investor owned 317,000 shares of the company’s stock after selling 25,500 shares during the period. Clark Estates Inc. NY’s holdings in Pediatrix Medical Group were worth $3,674,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MD. nVerses Capital LLC acquired a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth approximately $31,000. Innealta Capital LLC purchased a new position in shares of Pediatrix Medical Group in the second quarter valued at $33,000. Quest Partners LLC raised its stake in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Pediatrix Medical Group by 47.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after buying an additional 1,524 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $72,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. StockNews.com cut shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Thursday, November 21st. Mizuho raised their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. UBS Group upped their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Truist Financial upped their target price on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, Jefferies Financial Group lifted their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $16.10.

Insider Transactions at Pediatrix Medical Group

In related news, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the transaction, the director now owns 138,683 shares in the company, valued at approximately $2,128,784.05. The trade was a 16.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total transaction of $129,728.00. Following the sale, the executive vice president now directly owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 46,808 shares of company stock worth $673,157 in the last three months. 1.20% of the stock is currently owned by company insiders.

Pediatrix Medical Group Stock Performance

NYSE MD opened at $14.76 on Wednesday. The company has a 50-day moving average of $13.01 and a 200-day moving average of $10.10. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $16.41.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $511.20 million for the quarter, compared to analyst estimates of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Pediatrix Medical Group’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the business earned $0.29 EPS. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.